Compound ID | 1261
Class: Lipopolysaccharide synthesis inhibitor (LpxC inhibitor)
Spectrum of activity: | Gram-negative |
Details of activity: | Activity against Gram-negative pathogens including multidrug resistant. |
Institute where first reported: | Dong-A ST Pharm |
Highest developmental phase: | Preclinical |
Development status: | Active |